10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2015 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 16, 2016) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Revenues: | |||
| Product sales | $ 20,944 | 19,327 | 18,192 |
| Other revenues | 718 | 736 | 484 |
| Total revenues | 21,662 | 20,063 | 18,676 |
| Operating expenses: | |||
| Cost of sales | 4,227 | 4,422 | 3,346 |
| Research and development | 4,070 | 4,297 | 4,083 |
| Selling, general and administrative | 4,846 | 4,699 | 5,184 |
| Other | 49 | 454 | 196 |
| Total operating expenses | 13,192 | 13,872 | 12,809 |
| Operating income | 8,470 | 6,191 | 5,867 |
| Interest expense, net | 1,095 | 1,071 | 1,022 |
| Interest and other income, net | 603 | 465 | 420 |
| Income before income taxes | 7,978 | 5,585 | 5,265 |
| Provision for income taxes | 1,039 | 427 | 184 |
| Net income | 6,939 | 5,158 | 5,081 |
| Earnings per share: | |||
| Basic (in usd per share) | 9.15 | 6.80 | 6.75 |
| Diluted (in usd per share) | 9.06 | 6.70 | 6.64 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 758 | 759 | 753 |
| Diluted (in shares) | 766 | 770 | 765 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2015 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 16, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Net income | $ 6,939 | 5,158 | 5,081 |
| Other comprehensive (loss) income, net of reclassification adjustments and taxes: | |||
| Foreign currency translation losses | (247) | (196) | (80) |
| Effective portion of cash flow hedges | 7 | 323 | 2 |
| Net unrealized (losses) gains on available-for-sale securities | (241) | 24 | (226) |
| Other | 9 | 2 | (3) |
| Other comprehensive (loss) income, net of tax | (472) | 153 | (307) |
| Comprehensive income | 6,467 | 5,311 | 4,774 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2015 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 16, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Cash flows from operating activities: | |||
| Net income | $ 6,939 | 5,158 | 5,081 |
| Depreciation and amortization | 2,108 | 2,092 | 1,286 |
| Stock-based compensation expense | 322 | 408 | 403 |
| Deferred income taxes | (607) | (108) | (189) |
| Other items, net | (399) | (116) | 103 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (420) | 136 | (38) |
| Inventories | 481 | 327 | (7) |
| Other assets | 155 | (1) | (59) |
| Accounts payable | (12) | 228 | 60 |
| Accrued income taxes | 509 | (103) | (326) |
| Other liabilities | 1 | 534 | (23) |
| Net cash provided by operating activities | 9,077 | 8,555 | 6,291 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (594) | (718) | (693) |
| Cash paid for acquisitions, net of cash acquired | (359) | (165) | (9,434) |
| Purchases of intangible assets | (55) | (285) | 0 |
| Purchases of marketable securities | (25,977) | (25,878) | (21,965) |
| Proceeds from sales of marketable securities | 18,029 | 16,697 | 19,123 |
| Proceeds from maturities of marketable securities | 3,527 | 4,199 | 5,090 |
| Proceeds from sale of property, plant and equipment | 274 | 3 | 20 |
| Change in restricted investments, net | 0 | 533 | (520) |
| Other | (392) | (138) | (90) |
| Net cash used in investing activities | (5,547) | (5,752) | (8,469) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 3,465 | 4,476 | 8,054 |
| Repayment of debt | (2,400) | (5,605) | (3,371) |
| Repurchases of common stock | (1,867) | (138) | (832) |
| Dividends paid | (2,396) | (1,851) | (1,415) |
| Net proceeds from issuance of common stock in connection with the Companys equity award programs | 82 | 186 | 296 |
| Settlement of contingent consideration obligations | (253) | (92) | 0 |
| Other | 252 | 147 | (6) |
| Net cash (used in) provided by financing activities | (3,117) | (2,877) | 2,726 |
| Increase (decrease) in cash and cash equivalents | 413 | (74) | 548 |
| Cash and cash equivalents at beginning of period | 3,731 | 3,805 | |
| Cash and cash equivalents at end of period | 4,144 | 3,731 | 3,805 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2015 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2015 10-K (Filed: Feb 16, 2016) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2015 | Dec 31, 2014 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 4,144 | 3,731 |
| Marketable securities | 27,238 | 23,295 |
| Trade receivables, net | 2,995 | 2,546 |
| Inventories | 2,435 | 2,647 |
| Other current assets | 1,706 | 2,494 |
| Total current assets | 38,518 | 34,713 |
| Property, plant and equipment, net | 4,907 | 5,223 |
| Intangible assets, net | 11,641 | 12,693 |
| Goodwill | 14,787 | 14,788 |
| Other assets | 1,723 | 1,592 |
| Total assets | 71,576 | 69,009 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 965 | 995 |
| Accrued liabilities | 5,452 | 5,513 |
| Current portion of long-term debt | 2,250 | 500 |
| Total current liabilities | 8,667 | 7,008 |
| Long-term debt | 29,306 | 30,215 |
| Long-term deferred tax liability | 2,239 | 3,461 |
| Other noncurrent liabilities | 3,281 | 2,547 |
| Contingencies and commitments | ||
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding 754.0 shares in 2015 and 760.4 shares in 2014 | 30,649 | 30,410 |
| Accumulated deficit | (2,086) | (4,624) |
| Accumulated other comprehensive loss | (480) | (8) |
| Total stockholders equity | 28,083 | 25,778 |
| Total liabilities and stockholders equity | 71,576 | 69,009 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |